Seeking Alpha

Antares Pharma (ATRS +11%) jumps after reporting positive results from its Actual Human Use...

Antares Pharma (ATRS +11%) jumps after reporting positive results from its Actual Human Use study, to assess the effectiveness of self-administered Vibex Methotrexate for adult patients with rheumatoid arthritis. The company said that the results show that self-administration of the drug is safe and well tolerated. All 101 patients were able to self-administer the medication successfully following standardized training and review of written instructions.
Comments (4)
  • Loving it.
    25 Sep 2012, 12:25 PM Reply Like
  • Up, up and away .........................
    25 Sep 2012, 12:32 PM Reply Like
  • Antares is on the move! When is the planned NDA filing?
    25 Sep 2012, 05:30 PM Reply Like
  • hmmm... a lot of retrace yesterday.
    26 Sep 2012, 12:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)